Zinc may hold key to fighting liver disease New research from the Westmead Institute's Storr Liver Centre in collaboration with the Centre for Virus Research and Kirby Institute has shown that serum zinc may benefit liver disease in a way we never expected. The study, led by Dr Scott Read and Associate Professor Golo Ahlenstiel, demonstrated that zinc naturally inhibits the inflammatory and antiviral effects of interferon lambda 3 (IFN-λ3), a protein strongly associated with tissue damage in chronic liver disease. Lead author of the study, Dr Read, said the study provides the first evidence that zinc can act as a potent and specific inhibitor of IFN-λ3 in the context of viral infections such as hepatitis C and influenza. "We have demonstrated that zinc inhibits numerous facets of the liver's immune response to viruses that may be mediated by IFN-λ3." "Zinc interferes with IFN-λ3 binding to the interferon lambda receptor, which results in decre...